Schonfeld Strategic Advisors LLC Ovid Therapeutics Inc. Transaction History

Schonfeld Strategic Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.13 - $3.73 $31,613 - $37,673	-10,100 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$3.31 - $4.04 $33,431 - $40,804	10,100 New	10,100 $34,000
Q2 2021 Aug 16, 2021	SELL	$3.3 - $4.49 $211,200 - $287,360	-64,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.42 - $4.47 $154,880 - $286,080	64,000 New	64,000 $257,000
Q2 2018 Aug 14, 2018	SELL	$6.16 - $10.14 $126,403 - $208,072	-20,520 Closed	0 $0

Q4 2017 Feb 14, 2018	SELL	$6.12 - $12.31 $79,437 - $159,783	-12,980 Reduced 38.75%	20,520 $203,000
Q3 2017 Nov 14, 2017	BUY	$5.32 - $9.77 $178,220 - $327,295	33,500	33,500 $287,000

43.2M

5.9K

300

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $52.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.